Kandesartan Stada (Candesartan Cilexetil)

Candesartan cilexetil is used to manage conditions related to the renin‑angiotensin system.

• Hypertension: lowers blood pressure and reduces the risk of cardiovascular events.
• Heart failure: improves symptoms and decreases hospitalisation rates.
• Diabetic nephropathy: slows progression of kidney damage in patients with diabetes.

• Candesartan cilexetil is a selective antagonist of angiotensin II type 1 (AT1) receptors. By blocking AT1, it prevents angiotensin II‑mediated vasoconstriction and aldosterone secretion, leading to vasodilation, reduced sodium and water retention, and ultimately lower blood pressure and decreased cardiac workload.

Adverse reactions may occur with any medication and should be monitored by a healthcare professional.

Common Side Effects

• Dizziness: feeling light‑headed, especially after standing.
• Headache: mild to moderate intensity.
• Fatigue: unusual tiredness or lack of energy.
• Hyperkalemia: elevated potassium levels in blood tests.
• Cough: dry or mild throat irritation.
• Nasal congestion: blocked or runny nose.

Serious or Rare Side Effects

• Angioedema: swelling of face, lips, tongue or throat.
• Acute renal failure: sudden loss of kidney function.
• Hepatic injury: abnormal liver enzymes or jaundice.
• Severe hypotension: dangerously low blood pressure.
• Neutropenia: marked reduction in white blood cells.
• Anaphylactic reaction: life‑threatening allergic response.

Before initiating therapy, clinicians should assess patient‑specific factors and monitor relevant parameters.

• Blood pressure monitoring: ensure adequate control and avoid hypotension.
• Renal function assessment: check serum creatinine and eGFR regularly.
• Electrolyte surveillance: monitor potassium levels, especially if combined with potassium‑sparing agents.
• Hepatic impairment: use with caution in patients with liver disease.
• Pregnancy: avoid use unless benefits outweigh potential risks, as safety is not established.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Candesartan cilexetil may interact with other medicines, requiring dose adjustments or avoidance.

Major Interactions (Avoid)

• Aliskiren (in diabetic patients): increased risk of renal impairment and hyperkalemia.
• Potassium‑sparing diuretics or supplements: may cause dangerous hyperkalemia.
• ACE inhibitors: combined use can lead to excessive potassium rise and renal dysfunction.

Moderate Interactions (Monitor Closely)

• Thiazide diuretics: additive blood‑pressure‑lowering effect, monitor for hypotension.
• CYP3A4 inhibitors (e.g., ketoconazole): may increase candesartan levels, observe for side‑effects.